1 |
Baird DM, Rowson J, Wynford-Thomas D and Kipling D (2003) Extensive allelic variation and ultrashort telomeres in senescent human cells. Nat Genet 33, 203-207
DOI
|
2 |
Baerlocher GM, Mak J, Roth A, Rice KS and Lansdorp PM (2003) Telomere shortening in leukocyte subpopulations from baboons. J Leukoc Biol 73, 289-296
DOI
|
3 |
Lopez-Otin C, Blasco MA, Partridge L, Serrano M and Kroemer G (2013) The hallmarks of aging. Cell 153, 1194-1217
DOI
|
4 |
Kuilman T, Michaloglou C, Mooi WJ and Peeper DS (2010) The essence of senescence. Genes Dev 24, 2463-2479
DOI
|
5 |
Collado M, Blasco MA and Serrano M (2007) Cellular senescence in cancer and aging. Cell 130, 223-233
DOI
|
6 |
Campisi J and d'Adda di Fagagna F (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8, 729-740
DOI
|
7 |
Storer M, Mas A, Robert-Moreno A et al (2013) Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155, 1119-1130
DOI
|
8 |
Munoz-Espin D, Canamero M, Maraver A et al (2013) Programmed cell senescence during mammalian embryonic development. Cell 155, 1104-1118
DOI
|
9 |
Baker DJ, Wijshake T, Tchkonia T et al (2011) Clearance of p16Ink4a-positive senescent cells delays ageingassociated disorders. Nature 479, 232-236
DOI
|
10 |
Martin JA and Buckwalter JA (2002) Aging, articular cartilage chondrocyte senescence and osteoarthritis. Biogerontology 3, 257-264
DOI
|
11 |
Minamino T and Komuro I (2007) Vascular cell senescence: contribution to atherosclerosis. Circ Res 100, 15-26
DOI
|
12 |
Childs BG, Durik M, Baker DJ and van Deursen JM (2015) Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med 21, 1424-1435
DOI
|
13 |
Kim YH, Choi YW, Lee J, Soh EY, Kim JH and Park TJ (2017) Senescent tumor cells lead the collective invasion in thyroid cancer. Nat Commun 8, 15208
DOI
|
14 |
Haugstetter AM, Loddenkemper C, Lenze D et al (2010) Cellular senescence predicts treatment outcome in metastasised colorectal cancer. Br J Cancer 103, 505-509
DOI
|
15 |
Reimann M, Lee S, Loddenkemper C et al (2010) Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence. Cancer Cell 17, 262-272
DOI
|
16 |
Vizioli MG, Possik PA, Tarantino E et al (2011) Evidence of oncogene-induced senescence in thyroid carcinogenesis. Endocr Relat Cancer 18, 743-757
DOI
|
17 |
Denoyelle C, Abou-Rjaily G, Bezrookove V et al (2006) Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol 8, 1053-1063
DOI
|
18 |
Debacq-Chainiaux F, Erusalimsky JD, Campisi J and Toussaint O (2009) Protocols to detect senescenceassociated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 4, 1798-1806
DOI
|
19 |
Yoon JE, Kim Y, Kwon S et al (2018) Senescent fibroblasts drive ageing pigmentation: A potential therapeutic target for senile lentigo. Theranostics 8, 4620-4632
DOI
|
20 |
Dimri GP, Lee X, Basile G et al (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92, 9363-9367
DOI
|
21 |
Bennecke M, Kriegl L, Bajbouj M et al (2010) Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell 18, 135-146
DOI
|
22 |
Ancrile B, Lim KH and Counter CM (2007) Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev 21, 1714-1719
DOI
|
23 |
Jun JI and Lau LF (2010) The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol 12, 676-685
DOI
|
24 |
Liu D and Hornsby PJ (2007) Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res 67, 3117-3126
DOI
|
25 |
Parrinello S, Coppe JP, Krtolica A and Campisi J (2005) Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J Cell Sci 118, 485-496
DOI
|
26 |
Biran A, Zada L, Abou Karam P et al (2017) Quantitative identification of senescent cells in aging and disease. Aging Cell 16, 661-671
DOI
|
27 |
Krizhanovsky V, Yon M, Dickins RA et al (2008) Senescence of activated stellate cells limits liver fibrosis. Cell 134, 657-667
DOI
|
28 |
Coppe JP, Patil CK, Rodier F et al (2008) Senescenceassociated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6, 2853-2868
|
29 |
Kim YH, Choi YW, Han JH et al (2014) TSH signaling overcomes B-RafV600E-induced senescence in papillary thyroid carcinogenesis through regulation of DUSP6. Neoplasia 16, 1107-1120
DOI
|
30 |
Cisowski J, Sayin VI, Liu M, Karlsson C and Bergo MO (2016) Oncogene-induced senescence underlies the mutual exclusive nature of oncogenic KRAS and BRAF. Oncogene 35, 1328-1333
DOI
|
31 |
Dankort D, Curley DP, Cartlidge RA et al (2009) Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet 41, 544-552
DOI
|
32 |
Bos JL (1989) ras oncogenes in human cancer: a review. Cancer Res 49, 4682-4689
|
33 |
Tchkonia T, Zhu Y, van Deursen J, Campisi J and Kirkland JL (2013) Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest 123, 966-972
DOI
|
34 |
Hayflick L and Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25, 585-621
DOI
|
35 |
Herbert B, Pitts AE, Baker SI et al (1999) Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc Natl Acad Sci U S A 96, 14276-14281
DOI
|
36 |
Bodnar AG, Ouellette M, Frolkis M et al (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352
DOI
|
37 |
Munoz-Espin D and Serrano M (2014) Cellular senescence: from physiology to pathology. Nat Rev Mol Cell Biol 15, 482-496
DOI
|
38 |
Vicente R, Mausset-Bonnefont AL, Jorgensen C, Louis-Plence P and Brondello JM (2016) Cellular senescence impact on immune cell fate and function. Aging Cell 15, 400-406
DOI
|
39 |
Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602
DOI
|
40 |
Chen Z, Trotman LC, Shaffer D et al (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436, 725-730
DOI
|
41 |
Michaloglou C, Vredeveld LC, Soengas MS et al (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436, 720-724
DOI
|
42 |
Althubiti M, Lezina L, Carrera S et al (2014) Characterization of novel markers of senescence and their prognostic potential in cancer. Cell Death Dis 5, e1528
DOI
|
43 |
Collado M, Gil J, Efeyan A et al (2005) Tumour biology: senescence in premalignant tumours. Nature 436, 642
DOI
|
44 |
Krtolica A, Parrinello S, Lockett S, Desprez PY and Campisi J (2001) Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A 98, 12072-12077
DOI
|
45 |
Lee CJ, Suh EJ, Kang HT et al (2002) Induction of senescence-like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalized by HPV16 DNA. Exp Cell Res 277, 173-182
DOI
|
46 |
Sparmann A and Bar-Sagi D (2004) Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6, 447-458
DOI
|
47 |
el-Deiry WS, Harper JW, O'Connor PM et al (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54, 1169-1174
|
48 |
Di Leonardo A, Linke SP, Clarkin K and Wahl GM (1994) DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 8, 2540-2551
DOI
|
49 |
Liu M and Pelling JC (1995) UV-B/A irradiation of mouse keratinocytes results in p53-mediated WAF1/CIP1 expression. Oncogene 10, 1955-1960
|
50 |
Stein GH, Drullinger LF, Soulard A and Dulic V (1999) Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol 19, 2109-2117
DOI
|
51 |
Gabay C (2006) Interleukin-6 and chronic inflammation. Arthritis Res Ther 8 Suppl 2, S3
DOI
|
52 |
Kunkel SL, Standiford T, Kasahara K and Strieter RM (1991) Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res 17, 17-23
DOI
|
53 |
Coppe JP, Desprez PY, Krtolica A and Campisi J (2010) The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 5, 99-118
DOI
|
54 |
Freund A, Orjalo AV, Desprez PY and Campisi J (2010) Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med 16, 238-246
DOI
|
55 |
Ho IA, Yulyana Y, Sia KC et al (2014) Matrix metalloproteinase-1-mediated mesenchymal stem cell tumor tropism is dependent on crosstalk with stromal derived growth factor 1/C-X-C chemokine receptor 4 axis. FASEB J 28, 4359-4368
DOI
|
56 |
Milde-Langosch K, Bamberger AM, Rieck G, Kelp B and Loning T (2001) Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype. Breast Cancer Res Treat 67, 61-70
DOI
|
57 |
Jaszewski R, Ehrinpreis MN and Majumdar AP (1999) Aging and cancer of the stomach and colon. Front Biosci 4, D322-328
DOI
|
58 |
Bleul CC, Farzan M, Choe H et al (1996) The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829-833
DOI
|
59 |
Chen JH, Stoeber K, Kingsbury S, Ozanne SE, Williams GH and Hales CN (2004) Loss of proliferative capacity and induction of senescence in oxidatively stressed human fibroblasts. J Biol Chem 279, 49439-49446
DOI
|